About Technology Issues FAQ

Links

Official Page

Randomized phase III trial of sorafenib in advanced renal cell carcinoma (RCC): Impact of crossover on survival

Randomized phase III trial of sorafenib in advanced renal cell carcinoma (RCC): Impact of crossover on survival — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.